Marco Fariñas on HGSOC and multi omics approaches to study cancer-stroma interactions and drug sensitivity Lehti Lab PerMedCoE NTNU

Fantastic new tools to spy on protein movements inside and between cells from@aliceyting😀👏👍

Huge congratulations Viviam and Marco✨🏅 Wonderful to do research with the young talents. Looking forward to hear more what you learned and experienced in this exciting meeting! Åsmund Flobak @mtrkuiper Eirini Tsirvouli

Our new review is out (my first last author)! Here we discuss how cancer therapies reshape the #ECM - #immune microenvironment crosstalk and how can we exploit it to improve therapy response. authors.elsevier.com/a/1hWJc,LVEyDF…

This work resulted from Lara Closset’s efforts during the pandemic that continued until now and great contributions from Okan Gültekin, PhD Lehti Lab @DhifafSarhan Dr. Salehi

Excited to announce our next session: "BMP signaling and vascular biology" chaired by Paul Yu Aug. 23. Mohamed Al-Shabrawey and Lei Wang are presenting their interesting work. Please share! Register here: docs.google.com/forms/d/1k_k_z…

Today Cell, Cancer Cell and Cell Reports Medicine are pleased to publish the 1st wave of Pan-#Cancer multiomics papers looking at over 1000 patients across 10 #tumor types from National Cancer Institute Clinical Proteomic Tumor Analysis Consortium #CPTAC (1/n) Cancer Cell Cell Reports Medicine #openaccess

Fantastic news! Congratulations to NTNU professors James R. Dawson and Thorsten Hamann. The two ERC SYNERGY grants represent two important research topics, which will be exciting to follow in future.

We recruit one PHD candidate for cell lab work on functional precision medicine. Colon cancer cells direclty from patients are exposed to drugs to find the best therapy for each patient. Deadline Nov 22nd: jobbnorge.no/en/available-j… NTNU SINTEF St. Olavs hospital MATRIX

Åsmund Flobak NTNU SINTEF St. Olavs hospital MATRIX Du har ikke noen ovarialcancerceller vi kan gjøre det samme med da? 😁

”The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients” Congratulations and thank you for the opportunity to participate Brinton Seashore-Ludlow, Emma Åkerlund and all co-authors! lnkd.in/dTTQS2vF

Dr. Åsmund Flobak's team at @NTNUnorway presents a systematic 📖 #review of studies that tested the performance of patient-derived #organoids to predict the effect of anti-cancer therapies in #ColorectalCancer, for chemotherapies, and more! Scientific Reports | bitly.ws/YJ6e

.seashoreludlow and colleagues at KI and SciLifeLab present a #PrecisionMedicine platform with 3D cell cultures that can identify effective drugs and drug combinations for #OvarianCancer patients. The study is published in npj Journals Precision #Oncology doi.org/10.1038/s41698…

The Norwegian government wants to implement a new rule requiring all temporary employees (PhD students and postdocs) to obtain 15 credits in Norwegian language within their 3 years contract. This piece written by Karina Rose Mahan NTNU is very relevant! sciencenorway.no/education-empl…

Over 35 million new cases are predicted in 2050, a 77% increase vs cases in 2022. Tobacco🚬, alcohol🍺🍷 & obesity🍔 are key lifestyle risk factors behind the increasing incidence. Air pollution remains a major environmental risk factor🌬️. iarc.who.int/news-events/gl…

Check out this this exiting study from @DhifafSarhan lab on the recently discovered adaptive NK cells, recruited to ovarian cancers by CXCR2!

Happy to share our new study on the mechanical regulation of ovarian cancer invasion into adipose tissues! Here we develop adipose tissue-mimicking organo-hydrogels to investigate how cells invade these tissues, a central process in the establishment of metastases!